Biomedical Equity for NextGen Trials and Outcomes (“BENTO”) is a patient biosampling and engagement platform for enabling all-scale decentralized clinical trials and precision medicine research. All BENTO specimen collection and eCOA tools have been patient-designed to make study participation a gamified, consumer-grade experience, with self-sovereignty mechanisms to elevate patient voices and cultivate trust in medically underrepresented communities. To learn more, visit www.bentobio.com

Boston Scientific Cardiac Diagnostics, Clinical Services is a leading provider of remote ECG monitoring technology for clinical trials. We collaborate with research professionals around the world and across the research industry to support academic, pharmaceutical, and medical device research with our patch-based ECG monitor, the BodyGuardian™ MINI. For more information, go to https://www.cdx.bostonscientific.com/us/en/home.html

BRANY is a national organization providing a continuum of compliance support services to investigators, hospitals, universities, academic medical centers, biotech, pharma and medical device companies. BRANY was founded in 1998 and is currently owned by four nationally ranked academic medical centers: NYU Grossman School of Medicine, Montefiore Medical Center, Icahn School of Medicine at Mount Sinai, and Northwell Health. BRANY IRB was the first IRB in New York to be accredited by AAHRPP in 2006. To find out more, visit www.brany.com

Lumanity applies incisive thinking and decisive action to confront complex situations and deliver transformative outcomes that optimize access to medical advances. Experienced in medical, commercial, and regulatory affairs, Lumanity transforms data and information into real-world insights that power successful commercialization and empowers patients, payers, and regulators to take timely action. For more information, visit: www.lumanity.com

BullFrog AI is a technology-enabled drug development service provider using explainable AI to aid in advancing the next generation of lifesaving therapies. Our exclusive platform created at Johns Hopkins University Applied Physics Laboratory, bfLEAP™, can analyze, display, and explain your data providing actionable insights to help optimize your program’s success. To find out more, visit https://bullfrogai.com/

CRIO revolutionizes clinical research with cutting-edge cloud technology. CRIO enables remote monitoring and instant data review with CRIO Reviewer, an integrated eSource/EDC solution. Capturing data in real-time and ensuring compliance with various regulations, including 21 CFR 11, ICH-GCP, GDPR, and HIPAA, CRIO eliminates redundant data entry and safeguards data integrity. For more information, please visit https://clinicalresearch.io/

ICON plc is a world-leading clinical research organisation powered by healthcare intelligence. From molecule to medicine, we advance clinical research providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organisations. We develop new innovations, drive emerging therapies forward and improve patient lives. With headquarters in Dublin, Ireland, ICON employed approximately 41,250 employees in 97 locations in 55 countries as at March 31, 2025. For further information about ICON, visit: www.iconplc.com.

Best Buy Health partners with pharmaceutical organizations to enable safe, high-quality, and effective care at home. Through its Current Health solution, Best Buy Health provides an enterprise care-at-home platform, integrated monitoring devices, and robust support services to accelerate and expand access to clinical trials, improve patient experience, and create rich digital data streams for biomarker development. To learn more, please visit www.currenthealth.com

Fortrea (Nasdaq: FTRE) is a leading global provider of clinical development and patient access solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients in need. Fortrea provides phase I-IV clinical trial management, clinical pharmacology, differentiated technology enabled trial solutions and post-approval services. Fortrea’s solutions leverage three decades of experience spanning more than 20 therapeutic areas, a passion for scientific rigor, exceptional insights and a strong investigator site network. Our talented and diverse team of more than 19,000 people working in more than 90 countries is scaled to deliver focused and agile solutions to customers globally. Learn more about how Fortrea is becoming a transformative force from pipeline to patient at Fortrea.com and follow us on LinkedIn and Twitter @Fortrea.

IgniteData’s Archer is the ultimate EHR-to-EDC data transfer technology to solve the clinical trial data challenge. System-agnostic and scalable, Archer provides fast, accurate transfer of regulatory-grade data from sites’ EHR to sponsors’ research systems: recent evidence from a live pilot study found that Archer can map and transfer 100% of Vital Signs and Labs data. Designed around the needs of researchers and study sites, Archer allows trials to dispense with laborious data transcription and reach go-live faster. Visit BOOTH 98 to learn more: www.ignitedata.com – follow our latest company news at www.linkedin.com

Interspond, founded in 2003, works with a network of Sites, and provides centralized
business development services. We identify study opportunities for Sites and provide top enrolling, high performing Sites to Sponsors and CROs for consideration
for participation. For more information, go to https://interspond.com/